ArticleCancer research2016

The BRCA1-Δ11q Alternative Splice Isoform Bypasses Germline Mutations and Promotes Therapeutic Resistance to PARP Inhibition and Cisplatin.

Yifan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.